Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-26-000100
Filing Date
2026-03-25
Accepted
2026-03-25 06:03:59
Documents
1
Period of Report
2026-03-25

Document Format Files

Seq Description Document Type Size
1 6-K form6k_032526.htm 6-K 27026
  Complete submission text file 0001395064-26-000100.txt   28025
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 26788245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)